School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan.
Division of Cardiovascular Medicine, Department of Medicine, China Medical University Hospital, Taichung, Taiwan.
Postgrad Med J. 2023 Jun 15;99(1172):566-569. doi: 10.1136/postgradmedj-2022-141557.
This study is on the use of the adapted Diabetes Complications Severity Index (aDCSI) for erectile dysfunction (ED) risk stratification in male patients with type 2 diabetes mellitus (DM).
This is a retrospective study with records obtained from Taiwan's National Health Insurance Research Database. Adjusted HRs (aHRs) were estimated by multivariate Cox proportional hazards models with 95% confidence intervals (CIs)..
A population of 84 288 eligible male patients with type 2 DM were included. Compared with change in aDCSI score of 0.0-0.5 per year, the aHRs and the corresponding 95% CIs for other changes in aDCSI scores are summarised as follows: 1.10 (0.90 to 1.34) for change in aDCSI score of 0.5-1.0 per year; 4.44 (3.47 to 5.69) for change in aDCSI score of 1.0-2.0 per year; and 10.9 (7.47 to 15.9) for change in aDCSI score of >2.0 per year..
Progression in aDCSI score might be used for ED risk stratification in men affected by type 2 DM.
本研究旨在使用改良的糖尿病并发症严重程度指数（aDCSI）对 2 型糖尿病男性患者的勃起功能障碍（ED）风险进行分层。
这是一项回顾性研究，记录来自台湾全民健康保险研究数据库。通过多变量 Cox 比例风险模型估计调整后的 HR（aHR），并给出 95%置信区间（CI）。
纳入了 84288 名符合条件的 2 型糖尿病男性患者。与 aDCSI 评分每年变化 0.0-0.5 分相比，其他 aDCSI 评分变化的 aHR 及其相应的 95%CI 总结如下：每年变化 0.5-1.0 分的 aHR 为 1.10（0.90 至 1.34）；每年变化 1.0-2.0 分的 aHR 为 4.44（3.47 至 5.69）；每年变化 >2.0 分的 aHR 为 10.9（7.47 至 15.9）。
aDCSI 评分的进展可用于 2 型糖尿病男性患者 ED 风险分层。
Zotero 插件